Skip to main content


  • Thursday, Nov 13th
    1:15 PM - 2:15 PM EST
    Plenary HemePath
    Program Committee Moderator: Amir Behdad, n/a – Cleveland Clinic Florida
    Program Committee Moderator: Joanna Conant, MD (she/her/hers) – University of Vermont
  • Thursday, Nov 13th
    1:15 PM - 2:15 PM EST
    Genomic Classification and Individualized Prognosis in Multiple Myeloma
    Plenary Speaker: C. Ola Landgren, MD, PhD (he/him/his) – University of Miami, Sylvester Comprehensive Cancer Center
  • Thursday, Nov 13th
    2:30 PM - 3:30 PM EST
    Molecular Testing Standards and Guidelines for Measurable Residual Disease Testing in Acute Myeloid Leukemia: A Report of the AMP (PLACEHOLDER)
  • Friday, Nov 14th
    10:15 AM - 11:00 AM EST
    Rapid Epigenomic Classification of Acute Leukemia
    Breakout Speaker: Gabriel Griffin, MD (he/him/his) – Dana-Farber Cancer Institute
  • Friday, Nov 14th
    1:15 PM - 2:00 PM EST
    DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma
    Breakout Speaker: Christopher Oakes, PhD – The Ohio State University
  • Friday, Nov 14th
    2:00 PM - 2:45 PM EST
    Fluctuating DNA methylation and evolutionary history in lymphoid cancers
    Breakout Speaker: Trevor Graham, PhD – Institute of Cancer Research, London, UK
  • Saturday, Nov 15th
    10:15 AM - 11:00 AM EST
    Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities (Panel discussion)
    Breakout Speaker: Annette S. Kim, MD, PhD (she/her/hers) – University of Michigan
  • Saturday, Nov 15th
    11:00 AM - 11:45 AM EST
    Panel
    Breakout Speaker: Marlise R. Luskin, MD MSCE (she/her/hers) – Dana-Farber Cancer Institute